Concord Medical Services Stock (NYSE:CCM)
Previous Close
$5.61
52W Range
$3.80 - $26.70
50D Avg
$7.86
200D Avg
$7.67
Market Cap
$26.65M
Avg Vol (3M)
$20.51K
Beta
-0.25
Div Yield
-
CCM Company Profile
Concord Medical Services Holdings Limited, together its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company operates in two segments, Network and Hospital. Its services include linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, and diagnostic imaging services. The company's other treatments and diagnostic services comprise computed tomography scanners. In addition, it provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, the company offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, it operates specialty cancer hospitals, which offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. As of December 31, 2021, it operated a network of 16 cooperative centers based in 13 hospitals. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.
CCM Performance
Revenue Breakdown
Revenue Breakdown by Product/Service
Product/Service | Dec 23 | Dec 22 | Dec 21 |
---|---|---|---|
Medicine income | $100.46M | $85.71M | $59.32M |
Services and other revenues | $500.07M | $364.41M | - |
Equipment Leasing Revenues | $16.74M | $21.97M | - |
Medical service | - | - | $101.85M |
Consumable and equipment sales | - | - | $217.38M |
Management services and technical services | - | - | $64.60M |
Fiscal year ends in Dec 23 | Currency in USD